Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1762 results about "Bio engineering" patented technology

Biological engineering, or bioengineering/bio-engineering, is the application of principles of biology and the tools of engineering to create usable, tangible, economically viable products.

System and method to bioengineer facial form in adults

A method and apparatus are provided for changing the form of the jaw and facial bones of an adult patient that did not develop fully during childhood. The method utilizes a device having a plate body with an expansion screw that fits within the mouth of the patient; flap springs that project from the plate body, and an overlay extending from the plate body. The device is placed within the mouth of the patient so that the overlay is in a position between at least two opposing teeth. In this position, opposing teeth contact the overlay during function (e.g. swallowing). This intermittent, unilateral application of force to the facial bones causes these bones to further develop, positioning out of place teeth into more proper positions, and inducing a more symmetrical and enhanced appearance of the face, as well as increasing the airway space behind the jaws. Concomitantly, the flap springs gently press against selected teeth that are out of alignment in order to guide those teeth into place. Simultaneously, the expansion device maintains these forces on the teeth, while assisting the jawbones to expand to accept the teeth in their proper position. The expansion device can be adjusted by small motors under the control of a microprocessor located on the body plate based on readings from sensors on the flap springs. The expansion device can be adjusted by remote signaling, using a global position satellite technology and global position coordinates.
Owner:BELFOR THEODORE +1

Peptide for high performance inhibition of angiogenesis and method for preparing same and use thereof

ActiveCN1699408AImprove and enhance growthImprove and enhance the anti-tumor effectPeptide/protein ingredientsSkeletal disorderEscherichia coliInclusion bodies
The invention relates to a peptide for high performance inhibition of angiogenesis and method for preparing same and use, wherein high performance blood vessel production inhibiting agent RGD-ED with integration compatibility is designed, the inhibiting agent comprises polypeptide polypeptide-valine-arginine-arginine-alanine-aspartate-arginine-alanine-alanine-valine-praline, its one or two ends are connected with polypeptides containing arginine-glycine-aspartic acid sequence. The RGD-ED provided by the invention can be synthesized. The invention also discloses the expression of one RGD-ED in bacillus coli through gene engineering method, wherein the RGD-ED is prepared through the steps of inclusion body protein segregation, dissolution and renaturation, and ion-exchange chromatography segregation and purification.
Owner:CHINA PHARM UNIV

Programmed-release, nanostructured biological construct

A biologically engineered construct comprising of a polymeric biomatrix, designed with a nanophase texture, and a therapeutic agent for the purpose of tissue regeneration and / or controlled delivery of regenerative factors and therapeutic substances after it is implanted into tissues, vessels, or luminal structures within the body. The therapeutic agent may be a therapeutic substance or a biological agent, such as antibodies, ligands, or living cells. The nanophase construct is designed to maximize lumen size, promote tissue remodeling, and ultimately make the implant more biologically compatible. The nano-textured polymeric biomatrix may comprise one or more layers containing therapeutic substances and / or beneficial biological agents for the purpose of controlled, differential substance / drug delivery into the luminal and abluminal surfaces of the vessel or lumen, and the attraction of target molecules / cells that will regenerate functional tissue. The topographic and biocompatible features of this layered biological construct provides an optimal environment for tissue regeneration along with a programmed-release, drug delivery system to improve physiological tolerance of the implant, and to maximize the cellular survival, migration, and integration within the implanted tissues.
Owner:SCHAPIRA JAY N +1

Bioengineered tissue constructs and methods for production and use

Bioengineered constructs are formed from cultured cells induced to synthesize and secrete endogenously produced extracellular matrix components without the requirement of exogenous matrix components or network support or scaffold members. The bioengineered constructs of the invention can be treated in various ways such that the cells of the bioengineered constructs can be devitalized and / or removed without compromising the structural integrity of the constructs. Moreover, the bioengineered constructs of the invention can be used in conjunction with biocompatible / bioremodelable solutions that allow for various geometric configurations of the constructs.
Owner:ORGANOGENESIS

Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration

A biologically engineered construct comprising of a polymeric biomatrix, designed with a nanophase texture, and a therapeutic agent for the purpose of tissue regeneration and/or controlled delivery of regenerative factors and therapeutic substances after it is implanted into tissues, vessels, or luminal structures within the body. The therapeutic agent may be a therapeutic substance or a biological agent, such as antibodies, ligands, or living cells. The nanophase construct is designed to maximize lumen size, promote tissue remodeling, and ultimately make the implant more biologically compatible. The nano-textured polymeric biomatrix may comprise one or more layers containing therapeutic substances and/or beneficial biological agents for the purpose of controlled, physiological, differential substance/drug delivery into the luminal and abluminal surfaces of the vessel or lumen, and the attraction of target molecules/cells that will regenerate functional tissue. The topographic and biocompatible features of this layered biological construct provides an optimal environment for tissue regeneration along with a programmed-release, drug delivery system to improve physiological tolerance of the implant, and to maximize the cellular survival, migration, and integration within the implanted tissues.
Owner:SCHAPIRA JAY N +1

Method of producing cellulose, lignin and xylose by biomass material

A method for using biomass to produce cellulose, lignin and wood sugar comprises that breaking and screening the biomass, using low-boiling-point organic acid to immerge to decompose the biomass into wood sugar and oligosaccharide, and fluidize the cellulose and lignin, cools the liquid biomass after reaction, adds organic solvent, mixes uniformly and lays, after deposits completely, separating deposits and washes, dries to obtain non-shaped cellulose, distills the mother liquid of cellulose, recycles organic acid and generated volatile organics, distills mother liquid, cools and lays until complete deposition, separates deposits, washes, and dries to obtain wood sugar and oligosaccharide, evaporates to recycle the wood sugar and the organic solvent of deposited mother liquid, then separates the deposits, and dries to obtain lignin. The invention can completely circulate organic acid and organic solvent without waste discharged.
Owner:深圳市利世隆科技有限公司 +1

Extracting and processing technique of carrageen

The invention relates to an extracting and processing technique of carrageen by utilizing eucheuma, which comprises the procedures of cleaning, alkali treatment, washing, enzymatic hydrolysis, extracting, filtering, potassic alteration, dehydration, crushing and drying. By adopting enzyme biotechnology technology, the extraction rate and quality of carrageenan are improved, while the production cycle and energy consumption thereof being lowered. Colloid dissolves out of carrageen cells completely after the organization of cellulose in carrageen cell wall being destroyed during the procedure of enzymatic hydrolysis, thus improving the extraction rate of carrageenan. Meanwhile, the time of boiling procedure is shortened and the temperature thereof is lowered. The yield of products is increased and steam consumption during the process is reduced. Small molecule pigments also dissolve out of carrageen cells during the procedure of enzymatic hydrolysis, thus improving the transparency and purity of the obtained carrageenan. Since alcohol is adopted in dehydration procedure, the water content of the products is greatly reduced. Meanwhile, bactericidal effect of alcohol is favorable to inhibit the breeding of microorganisms during the process, thereby fulfilling the objective of disinfection and bacteriostasis. The above technique has the advantages of high extraction efficiency, high utilization rate of raw materials and high transparency and purity of the obtained carrageenan.
Owner:青岛聚大洋藻业集团有限公司

Saccharomyces cerevisiae strain with high yield of ester and low yield of higher alcohol as well as building and application of saccharomyces cerevisiae strain

PendingCN105385615AReduce outputOvercome flavor incongruityFungiHydrolasesEster hydrolaseBio engineering
The invention discloses a saccharomyces cerevisiae strain with high yield of ester and low yield of higher alcohol as well as a building method of the saccharomyces cerevisiae strain, and belongs to the technical field of bioengineering. According to the building method provided by the invention, through completely knocking out an amino acid transaminase gene BAT2 and an ester hydrolase gene IAH1 in an original strain, and selecting a strong promoter PGK1 over-expression alcohol acetyltransferase I gene ATF1 at the same time, the saccharomyces cerevisiae strain with high yield of ester and low yield of higher alcohol is obtained. Compared with a parent strain, other fermentation performances of built recombinant bacteria are not affected, the total quantity of acetic acid ester is obviously increased and reaches 1303.6mg/L, wherein the content of ethyl acetate is 52 times that of the original strain, isoamyl acetate is increased to 73.7mg/L, the content of main higher alcohol is 151.8mg/L and is reduced by 61.4 percent in comparison with that of the original strain. By using the saccharomyces cerevisiae, ester yield is significantly increased while the higher alcohol yield is reduced, the higher requirements of white spirit related fields on yeast are met and the application prospect is wide.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Biologically engineered stent

InactiveUS20100161032A1Promote formationPromote endothelial cell chemotaxisStentsOrganic active ingredientsMedicineIsograft
Biologically engineered stents are provided, some having novel double-walled and hybrid composition constructions that are suitable for multi-drug delivery. Some embodiments of biologically engineered stents (BES) in accordance with the invention can deliver drugs in the form of gene therapy vectors to cells in the walls of stented vessels, thereby promoting local production of therapeutic factors that attract and enhance the formation of endothelium in the stented vessel. Other embodiments of BES include xenografts, allografts or isografts comprising sleeve-like natural matrices derived from vessels of animal and human subjects including postmortem human donors.
Owner:AVELLANET FRANCISCO

Cropping GST protein thermal induction fusion expression plasmid and preparation method thereof

InactiveCN101215573ASuitable for western blot experimentsWill not affect judgmentVector-based foreign material introductionDNA/RNA fragmentationEscherichia coliProtein target
The invention belongs to the technical field of biological engineering and in particular is a heat-induced fusion expression recombinant plasmid of truncated GST protein and a process for preparation. The invention selects utility truncated GST188 protein which is composed of 188aa as a carrier, a pXXGST-1 recombinant plasmid which expresses short peptide fusion protein in an escherichia coli heat-induced expression system and a heat-induced type pXXGST-2 recombinant plasmid which is used to express comparison to realize the aim of synthesizing short peptide creatures, which is especially provided for scanning, drawing, positioning antigen linear epitopes and identifying epitope motif. Experiments of the invention prove the adaptability and the applicability of the GST188 core protein which is used as the short peptide creatures expression vector, in antigen epitope scanning identification, and in particular when anti- recombinant target protein antiserum is used to indentify the epitope motif.
Owner:SHANGHAI INST OF PLANNED PARENTHOOD RES +2

Cross-linking adsorbent resin with ultrahigh magnetic property and preparation method thereof

The invention discloses a magnetic ultrahigh cross-linking adsorbent resin and a preparation method thereof, belonging to the field of magnetic resin. The ultrahigh cross linking adsorbent resin provided by the invention is formed by a framework and magnetic particles wrapped in the framework, wherein the resin framework has the following basic structural formula that the saturation magnetization intensity of the resin is 0.1-10e mu / g; and the average particle size of the resin is 60-300 mu m. The resin provided by the invention is synthesized by adopting a suspension polymerization method and a reaction system comprises an oil phase, magnetic particles and a water phase, wherein the magnetic particles are wrapped in a double layer mode through a coupling agent and a dispersing agent, thereby enhancing the acid-resistant property and oil-phase dispersing property of the magnetic particles; chloromethyl styrene is adopted as a monomer to be synthesized into magnetic chlorine balls by adopting a one-step method; and then, a cross-linking reaction is carried out on the magnetic chlorine balls under the condition of nitrogen protection and in the presence of a buffer agent, thereby preparing the magnetic ultrahigh cross-linking adsorbent resin. The magnetic ultrahigh cross-linking adsorbent resin prepared by the invention can be applied to the elimination of organic pollutants in water, in particular to micro-pollution organic matters, and has wide application prospects in the fields of biological engineering, chemical analysis and the like.
Owner:NANJING UNIV

Method for preparing xylose and arabinose by hydrolyzing lignocellulose

The invention discloses a method for preparing xylose and arabinose by hydrolyzing lignocelluloses in the technical field of biological engineering. In the method, aqueous oxalate solution is used for carrying out catalytic hydrolysis on crushed lignocelluloses; lignocelluloses hydrolysate solution and xylose resides are obtained by solid-liquid separation after the reaction; the hydrolysate solution is neutralized to obtain oxalate sediment and obtain solid oxalate by solid-liquid separation again; the oxalate reacts with sulfate in an acidizing tank for regeneration to obtain the aqueous oxalate solution; the oxalate solution is used repeatedly to catalyze next batch of lignocelluloses raw material. The invention uses oxalic acid as organic acid catalyst and has the advantages of high conversion rate, strong selectivity, less side reaction, being capable of recycling, and the like, the oxalic acid can replace regular inorganic acid catalyst, and the invention solves the problem thatthe traditional technology has equipment erosion, evaporating equipment scaling, serious pollution and the like and can be used for hydrolyzing the hemicellulose in lignocelluloses raw material and used for preparing the xylose and the arabinose.
Owner:TSINGHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products